Aprinox

Quick links to important sections

Aprinox

Method of action: Diuretic

Treatment option: Hypertension

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aprinox

Property Description
Active ingredient Bendroflumethiazide
Form Oral Tablet
Pharmacological class Thiazide Diuretic, Antihypertensive
Common use Management of high blood pressure and fluid retention
Origin Synthetic, Sulfonamide-derived drug

What Type of Medicine is Aprinox (Bendroflumethiazide)?

Aprinox is a prescription-only medication whose active component is Bendroflumethiazide. This compound is formally classified as a thiazide diuretic and is utilized as an antihypertensive agent. Aprinox is particularly known for its oral tablet form and its established history as a therapy in managing chronic conditions. It is chemically derived from the sulfonamide structure, confirming its origin as a synthetic drug.

Bendroflumethiazide is clinically recognized for its effectiveness in influencing the body’s water and salt balance. The designation "diuretic" confirms its core function of promoting the increased production and elimination of urine. This medication is often an initial choice for uncomplicated high blood pressure, highlighting its specific positioning within cardiovascular therapy. Other popular brands containing this same active ingredient include Neo-Naclex and Centyl.


What is the Purpose of a Thiazide Diuretic?

The general purpose of a thiazide diuretic is to help the body effectively reduce excess fluid and salts to relieve stress on the cardiovascular system. In clinical practice, diuretics are employed to treat high blood pressure and fluid retention.

By compelling the body to excrete more water and salts, Bendroflumethiazide successfully lowers the total volume of fluid circulating within the blood vessels. This compound is classified as an agent for uncomplicated essential hypertension, indicating its role in long-term pressure control. The medication's purpose is focused on supporting the management of fluid homeostasis and relieving volume stress, resulting in a stable decrease in high blood pressure and the reduction of abnormal fluid accumulation in tissues, known as oedema.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Aprinox?

Possible Side Effects and Safety Information

The official safety profile of Aprinox (Bendroflumethiazide) outlines potential adverse reactions categorized by frequency and the body systems affected, based strictly on government regulatory documents.

Adverse Reaction Scope

Classification Examples of Documented Adverse Reactions
Common Disturbances in body fluid and salt balance (electrolyte imbalances, such as low potassium or sodium); changes in blood chemistry (hyperglycaemia, hyperuricaemia).
Rare Serious blood disorders (agranulocytosis, thrombocytopenia), inflammation of the pancreas (pancreatitis), and acute ophthalmological conditions (acute angle-closure glaucoma).
System Classes Metabolism and Nutrition Disorders, Vascular Disorders, Gastrointestinal Disorders, and Blood and Lymphatic System Disorders.

High-Level Safety Considerations

The most frequently documented safety characteristic relates to the drug's effect on electrolyte balance, which is classified as a common adverse reaction and may require monitoring.

Specific safety restrictions apply, as the medication is formally contraindicated (should not be used) in patients with conditions such as the complete absence of urine output (anuria) and severe impairment of kidney or liver function (renal/hepatic insufficiency), according to official labeling.

Safety notes also exist for certain populations. Older adults may be more susceptible to fluid and salt imbalances. Its use during pregnancy and lactation is generally avoided due to potential risks to the fetus (e.g., neonatal jaundice) and suppression of milk production, as noted in regulatory texts. The risk of photosensitivity (skin reaction to light) is also documented.

Overdose and Emergency Response

Aprinox (Bendroflumethiazide) overdose is formally documented as a risk resulting from its potent physiological effect on fluid and electrolytes. The regulatory descriptions indicate that an overdose may present with signs of profound fluid and volume depletion, including symptoms such as nausea, vomiting, diarrhoea, excessive thirst, and muscle cramps.

The most serious outcomes are related to this depletion, encompassing cardiovascular and neurological compromise. Documented severe manifestations include Hypotension (low blood pressure), the onset of Peripheral Circulatory Failure, and signs of CNS Depression, such as drowsiness or lethargy, potentially leading to coma. Laboratory findings associated with overdose typically involve significant electrolyte abnormalities, such as Hypokalaemia (low potassium) and Hyponatraemia (low sodium). These imbalances are noted to be more severe in patients with pre-existing hepatic or renal impairment, and in the elderly population.

Regulatory authorities strictly mandate that immediate medical attention must be sought upon suspicion of an overdose, including contacting emergency services or a National Poisons Information Centre. This action is required even if initial signs of discomfort are absent. Because no specific antidote is known, clinical management is documented as being entirely symptomatic and supportive, centered on the restoration of fluid and electrolyte balance and the monitoring of vital signs.

Therapeutic Uses of Aprinox

What Aprinox Treats: Main Uses and Benefits

Aprinox (Bendroflumethiazide) is commonly used to manage therapeutic domains related to the long-term control of high blood pressure and the symptomatic relief of excess fluid in the body. This medication is used primarily for managing high blood pressure (essential hypertension) and addressing fluid retention (oedema).


Controlling Chronic Essential Hypertension

This area focuses on the medication's primary role in providing supportive management for people with high blood pressure, specifically uncomplicated essential hypertension. A therapeutic benefit is that it helps to ease the overall strain on the cardiovascular system. This management may assist with maintaining functional stability in conditions associated with chronic high blood pressure.


Relieving Symptomatic Fluid Overload (Oedema)

Aprinox is commonly used to address the physical manifestation of fluid overload, or oedema. This helps address symptoms related to systemic imbalance that cause swelling, especially in the ankles, feet, and legs. The medication helps to ease the physical discomfort and heaviness associated with tissue swelling and supports the patient during episodes of heightened discomfort.

“For patients, managing excess fluid may contribute to improved comfort during symptomatic periods and assist with maintaining functional stability.”


Supportive Fluid Management in Chronic Illness

The medication is also applied in conditions where oedema arises as a secondary effect of specific chronic organ conditions, such as Congestive Heart Failure, Nephrotic Syndrome, or Cirrhosis of the Liver. In these complex clinical scenarios, Aprinox may assist with managing volume overload and contributes to easing the overall symptom load, supporting a reduction in the functional stress on already compromised organs.

Quick Fact: Relief for Oedema (Swelling) helps to alleviate the physical discomfort associated with symptoms related to systemic imbalance.

Eligibility and Restrictions for Use

Who can and cannot use Aprinox?

Aprinox (Bendroflumethiazide) is a prescription-only medicine whose eligibility for use is strictly defined by regulatory health authorities. The official prescribing information details both eligible populations and specific conditions that prohibit or restrict its use.

Who Must Not Use Aprinox (Contraindications)

Aprinox is formally contraindicated and must not be used by patients with the following conditions:

  • Hypersensitivity: Known allergy to bendroflumethiazide, other thiazides, or sulfonamide-derived drugs.
  • Severe Organ Dysfunction: Severe insufficiency of the kidneys or liver, including the inability to produce urine (anuria).
  • Metabolic Instability: Certain severe electrolyte imbalances, such as refractory hypokalaemia (low potassium), hyponatraemia (low sodium), or hypercalcaemia (high calcium).
  • Other Conditions: Addison’s disease or symptomatic hyperuricaemia (which may be associated with gout).

Age and Physiological Restrictions

Population Regulatory Status
Children & Adults Use is established for approved indications (hypertension, oedema).
Elderly Patients Use is permitted, but requires special care and monitoring due to increased susceptibility to fluid and salt imbalances.
Pregnancy Not recommended/Avoided, especially during the third trimester.
Breastfeeding Not recommended, as the drug passes into breast milk and may suppress lactation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Co-administration with Lithium is formally documented as contraindicated. This restriction stems from Aprinox inhibiting the renal tubular elimination of Lithium, which can lead to dangerously elevated plasma concentrations and a risk of toxicity. Similarly, combining Bendroflumethiazide with specific antipsychotic agents like Pimozide, Sertindole, or Thioridazine is officially advised to be avoided because the diuretic’s effect of causing hypokalaemia may heighten the risk of severe ventricular arrhythmias.

The interaction profile also outlines requirements for administration timing. Anion Exchange Resins such as Colestyramine reduce the absorption of Bendroflumethiazide and therefore must be administered two hours prior to, or after, the diuretic dose to ensure adequate systemic exposure.

Pharmacodynamic interactions include an additive risk of electrolyte imbalance when used with agents like Corticosteroids, ACTH, or Loop Diuretics. Additionally, co-administration with NSAIDs results in the antagonism of the diuretic effect. Alcohol consumption is documented to potentiate the risk of orthostatic hypotension. The risk of these documented electrolyte imbalances is formally noted to be more severe in patients with hepatic or renal impairment as well as the elderly.

Mechanism of Action

How Aprinox Works: Mechanism of Action


Inhibition of Renal Salt Transporters

Aprinox, a thiazide-like compound, exerts its primary action by inhibiting the Na^+- Cl^- cotransporter (NCC) located on the apical membrane of epithelial cells in the kidney's distal convoluted tubule. This interaction, which is a form of competitive inhibition, alters the cellular pathway responsible for reabsorbing sodium ( Na^+) and chloride ( Cl^-) ions. The consequent increase in non-reabsorbed salt in the tubular fluid initiates an osmotic gradient, leading to increased excretion of water and a reduction in total circulating fluid volume.


Direct Vascular Smooth Muscle Modulation

The compound also engages a complementary, non-diuretic mechanism by modulating ion channels in the walls of resistance arteries. This activity encourages the relaxation and widening of arteries (vasodilation), which decreases the overall resistance to blood flow within the circulatory system.


Synergistic Physiological Cascade

The overall mechanism involves a synergistic physiological cascade where the reduction in fluid volume from the renal action combines with the decreased vascular resistance from the vessel modulation. This combined effect on fluid balance and systemic vascular tone contributes significantly to the drug's overall physiological effect profile.

Dosage and Administration Information

Aprinox (bendroflumethiazide) is a medicine administered orally as a tablet and must be taken exactly as prescribed by a healthcare provider. The official instructions for use define the specific dose, frequency, and administration method.

Administration and Dosing

Condition Initial Adult Dose Maintenance Adult Dose
Hypertension 2.5 mg once daily 2.5 mg once daily
Oedema 5 mg to 10 mg daily or on alternate days 2.5 mg to 10 mg two or three times weekly

It is recommended to swallow the tablets whole with a glass of water. Aprinox may be taken with or without food. Due to its expected increase in urine output, the medicine should be taken in the morning to avoid sleep disturbance from nocturia.

Special Dosing Rules

  • Children: Dosage is based on weight, with an initial dose up to 400 micrograms/kg of body weight daily, reducing to a maintenance dose of 50 to 100 micrograms/kg daily.
  • Elderly: The dose may need to be reduced in older patients, particularly if kidney function is impaired, due to the potential for electrolyte imbalance.

Missed Dose Instructions

If a dose is forgotten, take it as soon as it is remembered. However, if it is late in the afternoon, the missed dose should be skipped entirely to avoid the need to urinate during the night. Patients must not take a double dose to compensate for the forgotten one.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Aprinox

Evidence for Use in Essential Hypertension (High Blood Pressure)

Research for Aprinox (Bendroflumethiazide) was studied for managing high blood pressure (essential hypertension) through large-scale, long-term studies. These investigations primarily took the form of Randomized Controlled Trials (RCTs), where researchers evaluated the medication against placebo or other established blood pressure treatments. The studies explored long-term outcomes monitoring physiological strain or stress, specifically tracking the incidence of stroke and heart attack, and recording measured changes in blood pressure levels.

Findings from this extensive research base describe patterns observed in the studies for hypertension. The data show patterns related to measured blood pressure changes. Research describes these observations across various populations, including adults with mild to moderate high blood pressure, and patients with certain coexisting factors.

Evidence for Use in Oedema (Fluid Retention)

Research for Aprinox was evaluated in settings related to fluid retention, known medically as oedema. Research examined its utility for outcomes related to systemic or functional imbalance where excess fluid accumulates. Study designs for oedema have typically included open-label clinical trials and research exploring its use as combination therapy alongside other types of diuretics.

Clinical reports describe observations related to volume management for patients with conditions marked by functional limitations due to fluid overload, such as those linked to Congestive Heart Failure or severe liver and kidney conditions.

Understanding Evidence Gaps and Limitations

It is important to understand the known limitations within the research. Comparative evidence is lacking for many direct comparisons against the newest classes of blood pressure or diuretic medications available today. Furthermore, there is limited information for long-term outcomes for its isolated use. These limitations highlight what is known — and what is still uncertain — about the use of Aprinox. Research provides context but not individual predictions.

Key Studies & References

  1. WHO ATC Code Classification: Bendroflumethiazide (C03AA01)
  2. PubChem Chemical Structure Information: Bendroflumethiazide
  3. MedlinePlus Reference: Diuretics and Fluid Retention

Frequently Asked Questions (FAQ)

Common questions about Aprinox (FAQ)

Q: How quickly does Aprinox start to work after taking it?

Official information indicates that the initial diuretic (water-reducing) action typically begins approximately two hours after a dose is taken. The peak effect is generally noted about four hours following administration, with the overall duration of effect lasting longer than this initial period.


Q: Can Aprinox cause low potassium levels?

Yes, official documents confirm that Aprinox can increase the risk of disturbances in the body's salt balance, known as electrolyte imbalances. Specifically, it may lead to low potassium (hypokalaemia) because the drug's mechanism alters how the kidneys manage salt reabsorption.


Q: What is the difference between Aprinox and indapamide (a similar drug)?

Aprinox (bendroflumethiazide) and indapamide are related diuretics, but they have different official classifications. Aprinox's active ingredient is formally categorized as a thiazide diuretic, while indapamide is defined as a thiazide-like diuretic. These classifications are based on differences in their chemical structure and how they work in the body.


Q: Do I need to get blood tests regularly while taking Aprinox?

Regulatory documents state that regular blood tests to determine serum electrolyte levels are commonly noted as necessary in official documents, particularly for patients receiving long-term treatment. This monitoring is used to check for imbalances in salts and minerals, such as potassium and sodium.


Q: Is it normal to have muscle cramps while taking Aprinox?

Muscle pain and cramps are symptoms that are described in patient information leaflets as potential signs of an underlying salt imbalance. Because Aprinox can affect potassium levels (hypokalaemia), cramps are noted as a possible result of this common adverse reaction.


Q: What are the main reasons someone would have to stop taking Aprinox?

The official prescribing information lists conditions that require immediate discontinuation of the drug. These include the acute onset of a serious eye condition (acute angle-closure glaucoma) or the detection of very high calcium levels (marked hypercalcaemia).


Q: Why do doctors often choose Aprinox over alternatives?

Regulatory assessment reports describe Aprinox as having an established history and a verified role in managing long-term blood pressure control. The documentation regarding its established role and long-standing use notes that the drug is often an initial choice for the management of uncomplicated high blood pressure.


Q: Will I feel different right after taking Aprinox?

The official safety profile notes that common side effects can include feeling dizzy (particularly on standing), thirst, or dry mouth, which may be felt soon after starting the medication. These feelings are related to the blood pressure lowering effect or the initial fluid changes in the body.


Q: How long does the effect of Aprinox usually last?

The duration of the main diuretic action is described in regulatory texts as persisting for approximately six to twelve hours after a dose is taken. This duration supports the practice of taking the medication once daily.


Q: Is Aprinox safe to take with common pain relievers like ibuprofen?

Official regulatory guidance notes that when Aprinox is co-administered with non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, it can result in the antagonism of the diuretic effect. This means the pain reliever may make Aprinox less effective at removing fluid.


Q: Is there a risk of interaction between Aprinox and lithium?

Co-administration of Aprinox and lithium is formally contraindicated, meaning its use is formally prohibited in combination with Lithium, according to official labelling. The reason is that Aprinox inhibits the way the kidneys eliminate lithium, which can lead to dangerously elevated lithium levels and a high risk of toxicity.


Q: Can Aprinox be taken at the same time as other heart medications?

The drug's official information addresses its use alongside other heart medications. It specifically notes that the risk of hypokalaemia (low potassium) caused by Aprinox can increase the possibility of abnormal heart rhythms, particularly in patients who are also taking certain anti-arrhythmic or digitalis heart preparations.


Q: What should I know about taking Aprinox if I have diabetes?

Regulatory information indicates that thiazide diuretics have the potential to lower carbohydrate tolerance and may potentially aggravate diabetes mellitus. Due to this documented risk, official texts describe that special care is necessary for patients with diabetes.


Q: Is Aprinox a medicine that I have to take forever?

Aprinox is primarily used to manage chronic, long-term conditions like high blood pressure and fluid retention. Regulatory patient information generally describes the treatment for such conditions as being likely long-term, and its use involves regular, continuous intake for condition management.


Q: Can Aprinox cause changes to my blood sugar test results?

Yes, official safety documents indicate that the drug can potentially cause hyperglycaemia (high blood sugar) and may lower the body's carbohydrate tolerance. Because of these documented effects, it may cause changes to the blood sugar levels measured by diagnostic tests.


Q: Is there a warning about sun exposure when using Aprinox?

Yes, official safety texts list photosensitivity (increased sensitivity to sunlight) as a potential adverse reaction. Official documents note that protective measures against sunlight are required to manage this documented risk.


Q: How long does it take for Aprinox to clear out of the body?

Pharmacology texts document that the half-life of Aprinox's active ingredient is approximately three to four hours. This figure indicates the time it takes for half of the drug to be eliminated from the body's system.


Q: Can I drink coffee or tea while taking Aprinox?

Regulatory-linked patient information suggests that drinks containing caffeine, such as coffee and tea, can increase thirst and the frequency of urination. This may potentiate, or enhance, the diuretic effect of Aprinox.


Q: What should I do if I get sick with vomiting or diarrhea while on Aprinox?

Official documents note that patients who are experiencing vomiting or diarrhoea are at an increased risk of severe fluid and electrolyte imbalance. Official documents note that careful observation and monitoring are necessary due to the risk of severe fluid and electrolyte imbalance during acute illness.


Q: Does Aprinox have a known effect on cholesterol levels?

Yes, regulatory texts document that the drug may have a deleterious effect on the lipid profile. This means the medication can potentially alter plasma lipids, such as resulting in increased cholesterol levels.


Q: Is Aprinox described as being a 'first-line' treatment?

The medication's role is confirmed in regulatory reports as being well-established for long-term pressure control. Official guidance notes that Aprinox is often described as an initial choice for the management of uncomplicated high blood pressure.


Q: Is it common to feel dizzy or lightheaded when starting Aprinox?

Dizziness or faintness on standing (known as postural hypotension) is explicitly noted in official product information as a potential common side effect. This feeling is related to the action of the drug lowering the overall blood pressure.


Q: Can Aprinox affect my sleep?

Official instructions recommend taking the tablet in the morning specifically so that its diuretic effect is active during the day. This is done to ensure sleep is not disturbed by the need to urinate frequently during the night.


Q: Does Aprinox cause weight loss?

The drug's primary mechanism leads to a reduction in fluid volume in the body, which may result in an observed decrease in body weight. However, weight loss is not listed as a primary therapeutic indication or a common adverse effect in official documents.


Q: Are there any known issues with drinking alcohol while using Aprinox?

Alcohol consumption is documented in regulatory sources to enhance the blood pressure-lowering effect of Aprinox. This combination can increase the possibility of experiencing side effects such as dizziness or fainting due to a sudden drop in blood pressure.


Q: Is Aprinox used for conditions other than high blood pressure and fluid retention?

Official product information does list other licensed indications for Aprinox. These include conditions where fluid retention is an issue, such as pre-menstrual oedema.

How should Aprinox be stored and disposed of?

How to Store and Dispose of Aprinox?

Aprinox (bendroflumethiazide) must be stored and handled according to specific regulatory requirements to maintain its stability and ensure safety.


Storage Requirements

Condition Regulatory Instruction
Temperature Do not store above 25 C (or 30 C in some regions).
Protection Keep in a dry place and protect from light.
Packaging Store in the original package with the container tightly closed.
Safety Keep out of the sight and reach of children.

Disposal Instructions

Unused or expired Aprinox must be disposed of in accordance with local regulatory requirements. The medicine should not be disposed of via household waste or wastewater to prevent environmental contamination, as instructed by regulatory guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aprinox found in:

A-Z Index: